The Finasteride Onset Curve: When Shedding Slows and Regrowth Begins

Finasteride does not work in a straight line. Understanding the actual curve — including the part where shedding temporarily increases — is what keeps people on the medication long enough for it to work.

The onset curve for finasteride is one of the most misunderstood aspects of the medication, and misunderstanding it is the primary reason people discontinue a treatment that would have worked if they had continued. The curve has a specific shape that needs to be known in advance — not because knowing it makes the difficult phases easier, but because a difficult phase that was expected is not a reason to stop, and the same phase that was not expected almost certainly is.

Before the first dose: the baseline period

Your current hair loss pattern, shedding rate, and density represent the baseline. Taking monthly scalp photographs starting now — before the first dose — gives you a reference point for everything that follows. Without this reference, the changes in shedding rate that come later are harder to evaluate accurately because you are relying on memory rather than comparison.

Good baseline photographs: overhead under diffuse natural light, front, and sides. Consistent position and consistent lighting across all future photographs. If you do not have these before starting, take them now anyway — the first photograph taken is the earliest reference available to you.

Weeks 1–2: Pharmacological onset

Finasteride reaches therapeutic blood levels quickly. Scalp DHT suppression begins within 24 hours of the first dose. By approximately two weeks, the medication has reached its steady-state suppression level — around 60–70% reduction in scalp DHT on standard 1mg daily dosing.

No visible hair change is expected or typically noticed in this period. The biology is changing; the hair cycle does not respond on a two-week timescale.

Months 1–3: The dread shed

This is the phase that ends most early discontinuations, and understanding it specifically is the most important part of this article.

The hair follicle cycle has three phases: anagen (growth), catagen (transition), and telogen (rest/shedding). DHT suppression by finasteride resets follicles that were trapped in shortened, miniaturising anagen cycles. As those follicles are reset, they transition to telogen and shed — all approximately together, because they were in the same compressed cycle.

The result is a period of temporarily increased shedding that typically begins within the first four to eight weeks and peaks somewhere between weeks six and twelve. This is not the medication making things worse. It is the medication doing what it is supposed to do: resetting a compromised cycle to allow a healthier one to begin.

The dread shed is evidence the medication is working. Stopping because of it is stopping precisely when continuing becomes most important.

The dread shed is not universal — some people do not experience it or experience it only mildly. But it is common enough that knowing about it before starting is standard preparation. The psychological challenge of watching shedding increase in the first weeks of a treatment intended to stop shedding is real; the clinical instruction is clear: continue.

Months 3–6: Stabilisation

Shedding slows. For most users who are going to respond, the elevated shedding of the dread shed phase resolves by month three or four. The new cycle has begun; hair that will grow to become the visible result is in the growth phase. Nothing visible is happening yet from the outside.

This is the plateau phase, which many people describe as harder than the dread shed because the drama is over but there is nothing to show for it yet. The shedding has calmed; there is no regrowth to look at; the medication is running. This phase requires patience and continued consistency.

Months 6–12: Early results

Fine regrowth appears at affected areas, typically the crown first, then mid-scalp. The early hairs are fine and may not be visible without close inspection or under specific lighting, but they are detectable in monthly comparison photographs. Between months six and nine, enough new hairs reach sufficient density and diameter to produce visible improvement for people who are going to respond well.

This is the phase where most people who discontinued during the dread shed would have seen their results — if they had continued.

Month 12: The assessment point

A fair assessment of finasteride response requires twelve months. Before this point, you are measuring a process in progress rather than a result. The appropriate twelve-month evaluation: comparison photographs against the baseline (taken before starting or as early as available), honest assessment of shedding rate relative to baseline, and if possible a clinical evaluation with trichoscopy or hair pull test.

If the twelve-month comparison shows stabilisation or improvement: the medication is working and should be continued. If it shows continued progression with no improvement: the response is genuinely limited and a discussion with a prescribing clinician about alternatives or additions is appropriate.